Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia

Inclusion Criteria:

1. Adult aged 19 or older at the time of the baseline visit.

2. A patient with hypertension and dyslipidemia who is scheduled to administer olomaxtablet according to investigator's medical judgement.

• Patients who were previously taking more than two tablets of a single drug,low-density lipoprotein-cholesterol (LDL-C)

• Patients who were previously only taking blood pressure-lowering drugs and didnot take LDL-C-lowering drugs, but who need to take additional LDL-C-loweringdrugs at the discretion of the researcher

• Patients who were previously taking LDL-C lowering agents and did not takeblood pressure lowering agents, but who need to take additional blood pressurelowering agents according to the researcher's judgment

• Patients who have not previously taken both a blood pressure drop and an LDL-Cdrop but need additional simultaneous use at the discretion of the researcher

3. A person who can understand the information provided to him/her and may voluntarilysign a written consent form

Exclusion Criteria:

1. A person who falls under the prohibition of administration according to thepermission for olomax tablet

2. A person who has a history of administering olomax tablets before participating inthis study

3. In addition to the above, a person that the investigator thinks he/she is notsuitable for participating in this observation study;